Marker Therapeutics, Inc.
MRKR
$1.27
$0.086.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.23M | 861.20K | 349.10K | 2.25M | 1.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23M | 861.20K | 349.10K | 2.25M | 1.93M |
| Cost of Revenue | -- | 4.18M | 3.14M | 5.09M | 3.00K |
| Gross Profit | 1.23M | -3.32M | -2.79M | -2.83M | 1.92M |
| SG&A Expenses | 1.02M | 945.20K | 1.37M | 1.03M | 854.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.37M | 5.12M | 4.50M | 6.11M | 4.33M |
| Operating Income | -2.14M | -4.26M | -4.16M | -3.86M | -2.40M |
| Income Before Tax | -2.00M | -4.02M | -4.45M | -3.79M | -2.31M |
| Income Tax Expenses | -- | -- | -- | 50.00K | -- |
| Earnings from Continuing Operations | -2.00M | -4.02M | -4.45M | -3.84M | -2.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.00M | -4.02M | -4.45M | -3.84M | -2.31M |
| EBIT | -2.14M | -4.26M | -4.16M | -3.86M | -2.40M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 |
| Normalized Basic EPS | -0.07 | -0.18 | -0.22 | -0.26 | -0.16 |
| EPS Diluted | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 |
| Normalized Diluted EPS | -0.07 | -0.18 | -0.22 | -0.26 | -0.16 |
| Average Basic Shares Outstanding | 16.76M | 13.96M | 11.11M | 9.18M | 8.92M |
| Average Diluted Shares Outstanding | 16.76M | 13.96M | 11.11M | 9.18M | 8.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |